Meeting of the National Vaccine Advisory Committee, 49038 [2021-18809]
Download as PDF
<![CDATA[
49038
Federal Register / Vol. 86, No. 167 / Wednesday, September 1, 2021 / Notices
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2021–18886 Filed 8–31–21; 8:45 am]
BILLING CODE 4150–25–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the National Vaccine
Advisory Committee
Office of Infectious Disease and
HIV/AIDS Policy, Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that the National Vaccine Advisory
Committee (NVAC) will hold a virtual
meeting. The meeting will be open to
the public and public comment will be
heard during the meeting.
DATES: The meeting will be held
September 14–15, 2021. The confirmed
meeting times and agenda will be
posted on the NVAC website at https://
www.hhs.gov/nvpo/nvac/meetings/
index.html as soon as they become
available.
SUMMARY:
Instructions regarding
attending this meeting will be posted
online at: https://www.hhs.gov/nvpo/
nvac/meetings/ at least one
week prior to the meeting. Preregistration is required for those who
wish to attend the meeting or participate
in public comment. Please register at
https://www.hhs.gov/nvpo/nvac/
meetings/.
FOR FURTHER INFORMATION CONTACT: Ann
Aikin, Acting Designated Federal
Officer, at the Office of Infectious
Disease and HIV/AIDS Policy, U.S.
Department of Health and Human
Services, Mary E. Switzer Building,
Room L618, 330 C Street SW,
Washington, DC 20024. Email: nvac@
hhs.gov. Phone: 202–494–1719.
SUPPLEMENTARY INFORMATION: Pursuant
to Section 2101 of the Public Health
Service Act (42 U.S.C. 300aa–1), the
Secretary of HHS was mandated to
establish the National Vaccine Program
to achieve optimal prevention of human
infectious diseases through
immunization and to achieve optimal
prevention against adverse reactions to
vaccines. The NVAC was established to
provide advice and make
recommendations to the Director of the
National Vaccine Program on matters
khammond on DSKJM1Z7X2PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
17:09 Aug 31, 2021
Jkt 253001
related to the Program’s responsibilities.
The Assistant Secretary for Health
serves as Director of the National
Vaccine Program.
During this NVAC meeting, NVAC
will hear presentations on vaccine
safety, vaccine development, and
communication activities. Please note
that agenda items are subject to change,
as priorities dictate. Information on the
final meeting agenda will be posted
prior to the meeting on the NVAC
website: https://www.hhs.gov/nvpo/
nvac/.
Members of the public will have the
opportunity to provide comment at the
NVAC meeting during the public
comment period designated on the
agenda. Public comments made during
the meeting will be limited to three
minutes per person to ensure time is
allotted for all those wishing to speak.
Individuals are also welcome to submit
written comments in advance. Written
comments should not exceed three
pages in length. Individuals submitting
comments should email their written
comments or their request to provide a
comment during the meeting to nvac@
hhs.gov at least five business days prior
to the meeting.
Dated: August 19, 2021.
Ann Aikin,
Acting Designated Federal Official, Office of
the Assistant Secretary for Health.
[FR Doc. 2021–18809 Filed 8–31–21; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–4040–0018]
Agency Information Collection
Request. 30-Day Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before October 1, 2021.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
SUMMARY:
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT:
Sagal Musa, sagal.musa@hhs.gov or
(202) 205–2634. When submitting
comments or requesting information,
please include the document identifier
4040–0018–30D and project title for
reference.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collections: SF–428
Tangible Personal Property Report.
Type of Collection: Extension.
OMB No.: 4040–0018.
Abstract: Reporting on the status of
Federally owned property, including
disposition, is necessitated in 2 CFR
part 215, the ‘‘Uniform Administrative
Requirements for Grants and
Agreements with Institutions of Higher
Education, Hospitals, and Other NonProfit Organizations’’, and the ‘‘Uniform
Administrative Requirements for Grants
and Agreements with State and Local
Governments’’, Additionally, Public
Law 106–107, the Federal Financial
Assistance Management Improvement
Act requires that agencies ’’simplify
Federal financial assistance application
and reporting requirements.’’ 31 U.S.C.
6101, Section 3.
Agencies are currently using a variety
of forms to account for both federally
owned and grantee owned equipment
and property. During the public
consultation process mandated by
Public Law 106–107, grant recipients
requested a standard form to help them
submit appropriate property
information when required. The Public
Law 106–107 Post Awards Subgroup
developed a new standard form, the
Tangible Personal Property Report, for
submission of the required data. The
form consists of the cover sheet (SF–
428), three attachments to be used as
required: Annual Report, SF–428–A;
Final Report, SF–428–B; Disposition
Request/Report, SF–428–C and a
Supplemental Sheet, SF–428S to
provide detailed individual item
information when required. The IC
expired on 6/30/2020. We are seeking
E:\FR\FM\01SEN1.SGM
01SEN1
]]>Agencies
[Federal Register Volume 86, Number 167 (Wednesday, September 1, 2021)]
[Notices]
[Page 49038]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18809]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the National Vaccine Advisory Committee
AGENCY: Office of Infectious Disease and HIV/AIDS Policy, Office of the
Assistant Secretary for Health, Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that the National Vaccine Advisory Committee (NVAC) will hold a virtual
meeting. The meeting will be open to the public and public comment will
be heard during the meeting.
DATES: The meeting will be held September 14-15, 2021. The confirmed
meeting times and agenda will be posted on the NVAC website at https://www.hhs.gov/nvpo/nvac/meetings/ as soon as they become
available.
ADDRESSES: Instructions regarding attending this meeting will be posted
online at: https://www.hhs.gov/nvpo/nvac/meetings/ at least
one week prior to the meeting. Pre-registration is required for those
who wish to attend the meeting or participate in public comment. Please
register at https://www.hhs.gov/nvpo/nvac/meetings/.
FOR FURTHER INFORMATION CONTACT: Ann Aikin, Acting Designated Federal
Officer, at the Office of Infectious Disease and HIV/AIDS Policy, U.S.
Department of Health and Human Services, Mary E. Switzer Building, Room
L618, 330 C Street SW, Washington, DC 20024. Email: [email protected].
Phone: 202-494-1719.
SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public
Health Service Act (42 U.S.C. 300aa-1), the Secretary of HHS was
mandated to establish the National Vaccine Program to achieve optimal
prevention of human infectious diseases through immunization and to
achieve optimal prevention against adverse reactions to vaccines. The
NVAC was established to provide advice and make recommendations to the
Director of the National Vaccine Program on matters related to the
Program's responsibilities. The Assistant Secretary for Health serves
as Director of the National Vaccine Program.
During this NVAC meeting, NVAC will hear presentations on vaccine
safety, vaccine development, and communication activities. Please note
that agenda items are subject to change, as priorities dictate.
Information on the final meeting agenda will be posted prior to the
meeting on the NVAC website: https://www.hhs.gov/nvpo/nvac/.
Members of the public will have the opportunity to provide comment
at the NVAC meeting during the public comment period designated on the
agenda. Public comments made during the meeting will be limited to
three minutes per person to ensure time is allotted for all those
wishing to speak. Individuals are also welcome to submit written
comments in advance. Written comments should not exceed three pages in
length. Individuals submitting comments should email their written
comments or their request to provide a comment during the meeting to
[email protected] at least five business days prior to the meeting.
Dated: August 19, 2021.
Ann Aikin,
Acting Designated Federal Official, Office of the Assistant Secretary
for Health.
[FR Doc. 2021-18809 Filed 8-31-21; 8:45 am]
BILLING CODE 4150-44-P
